Revenue on track, margins crumble under raw material inflation
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit revenue guidance; missed margin guidance. Withdrew specific margin targets; visibility admitted limited. Strategy coherent, execution credible on capex.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
DOMS nailed revenue (+19.2% on guidance) but margin collapse (-530 bps to 12.3% EBITDA) signals structural pressure under RM volatility. Management's volume-first strategy sacrifices near-term profitability. Recovery hinges on RM price stabilization and capacity ramp—both uncertain near-term. Long-term positioning solid, but FY27–28 profitability at risk.
₹670.5 Cr
Revenue · +19.2% YoY₹45.3 Cr
Reported PAT · −23.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 19.2% in line with annual guided range
METDelivered ₹670.5 Cr (+19.2% YoY); prior guidance was 17–20%. Hit upper-mid range.
Margin compression is temporary blip, not structural deterioration
OVERSTATEDEBITDA margin fell 530 bps (17.6%→12.3%); PAT fell 23.4% despite revenue +19.2%. Claim depends on RM prices normalizing—unverified at call time.
All core categories witnessed healthy growth
METScholastic, office supplies, art materials grew; e-commerce/modern trade strong. Export flattish due to West Asia. Claim supported by narrative.
Passed 4–5% price hikes to offset 20% raw material inflation
METRM prices up ~20%; company raised prices 4–5%, leaving ~500 bps unrecovered. Trade-off for volume/market share acknowledged.
Reynolds will contribute ~10% of revenues by FY29
MISSPrior Reynolds revenue ₹130–140 Cr; company targeting 10% of total (implies ~₹900+ Cr base). Capacity-constrained, not incremental volume.
Earnings quality
What changed since the last call
Margin guidance withdrawn
DowngradePrior target 16–17% EBITDA; Q1 delivered 12.3%. Visibility now limited due to RM volatility. De facto removal of specific margin guide.
Sales growth guidance narrowed and reinforced
NeutralPrior range 17–20%; call reinforced 18–20% for FY27. Upper end of prior range, not a raise, signalling confidence in volume but caution on upside.
Reynolds upside tempered
DowngradeManagement clarified Reynolds is capacity diversion, not incremental volume. No significant FY27 revenue lift. 10% of revenues by FY29 (not 20% as some misheard).
Price hike strategy locked in (no escalation planned)
NeutralManagement reinforced 4–5% price increases taken; no further hikes planned Q2. Will wait for RM stabilization. Strategic choice to defend market share over near-term margin.
The Q&A
Analysts pressed hard on why not take higher price hikes; management defended volume-led strategy citing market share gains vs unorganized players. Some skepticism on Reynolds incrementality, capacity constraints. Management held position; tone confident but cautious on RM outlook.
Margin trajectory — Kunal Vora, BNP Paribas
AnsweredYes, acknowledged temporary weakness. Once RM prices stabilize and new capacity ramps, margins will recover to 16–17% range. No further near-term price hikes planned.
Reynolds revenue outlook — Kunal Vora, BNP Paribas
AnsweredReynolds did ₹130–140 Cr prior. Target ~10% of company revenues by FY29. FY28 contribution marginal; capacity is diverted from DOMS, not incremental.
One-off cost quantification — Sneha, Nuvama Group
AnsweredESOP +0.2%, facility event +0.4%. RM inflation 20%, passed 4–5%, gap ~500 bps. Expects moderation in RM prices.
Pricing strategy rationale — Jinesh Joshi, PL Capital
AnsweredHistorical precedent: aggressive pricing during inflationary cycles allows small unorganized players breathing space. Strategy is to reduce that space via calibrated pricing and gain shelf space. Priority is volume-led growth, not near-term margin.
Reynolds nib business rationale — Jinesh Joshi, PL Capital
AnsweredNewell Group (Reynolds owner) wanted to retain tip manufacturing for global brands (Paper Mate, Sharpie, Parker). DOMS is setting up own tip plant; targeting 30–40% in-house manufacturing over 2 years.
Crude salience by segment — Aradhana Jain, 360 ONE Capital
PartialUniclan imports with long-term purchase orders at pre-agreed prices; lag effect means Q1 cost increase will hit Q2. Core stationery sourced locally, no lag.
Export challenges — Aradhana Jain, 360 ONE Capital
AnsweredMerchant exporters based in West India were impacted by global disruptions. Overall export decline (~12% of sales) flowed through. No structural regional mix change.
Capex efficiency and sales conversion — Rahul Agarwal, Ikigai Asset
AnsweredHistorical target ₹1 capex → ₹3 sales; achieved ~2.7x last year. 300K sq ft will ramp over 18–24 months to full utilization; part of 18–20% FY27 growth plan.
FY28 margin math — Rahul Agarwal, Ikigai Asset
PartialIf RM prices stay at current spot levels, need 4–5% additional price hikes to recover. FY28 targeting return to 16% EBITDA margin range.
Reynolds incremental capex question — Percy, IIFL Capital
AnsweredPhysical space is constraining. 50-acre project + 11 acres adjacent are under development. Building completion takes time; capex is already aggressive but cannot be rushed.
Reynolds margin profile — Anchit Jalan, Goldman Sachs Asset Management
AnsweredReynolds historically lower margin (Newell absorbed high costs). Under DOMS management, will operate at DOMS margin structure (~16% EBITDA target).
Margin bottom confirmation — Anchit Jalan, Goldman Sachs Asset Management
PartialHopefully. One-time facility costs + ESOP identified. Diaper seasonal pickup Q2 onwards should help. Assumes no major Trump tariff surprises.
Industry pricing alignment — Nihal Shah, Prudent Corporate Advisory
AnsweredIndustry was waiting for DOMS' decision. After DOMS increased, peers followed with similar calibrated increases. No aggressive outliers.
Margin recovery plan — Nihal Shah, Prudent Corporate Advisory
AnsweredWill add value to products (innovation, features) rather than pocket margin. Principle: nothing at cost of margin, nothing at cost of market. FY26 margins are sweet spot to target going forward.
Guidance
FY27 consolidated sales growth 18–20%
HighReiterated on call. In line with prior 17–20% range. Anchored on volume from back-to-school, capacity expansion, new launches, modern trade acceleration.
Visibility limited owing to RM price volatility
LowPrior target 16–17% EBITDA abandoned. Q1 delivered 12.3%. Management expects recovery once RM stabilizes but refused specific FY27/FY28 margin targets.
₹250–275 Cr capex planned for FY27
HighAlready invested ₹100 Cr in Q1. 50-acre greenfield + adjacent 11 acres + Jammu facility under development. Capex earmarked for facility buildout, not incremental Reynolds capex.
Risks the call surfaced
Raw material cost inflation
HighRM prices jumped ~20% in Q1; company passed only 4–5%, leaving ~500 bps margin gap. Recovery hinges on RM price stabilization, which remains uncertain due to West Asia crisis.
Export revenue headwinds
MediumExport growth flattish in Q1 due to West Asia disruptions (logistics, freight, shipment deferrals) and EU demand softness amid inflation. West Asia contributes ~2% of sales; still not fully opened.
Regional sales concentration risk
MediumWest India revenues down ~₹46 Cr (~24% YoY) due to merchant exporter base concentration and export-linked exposure. Reveals reliance on export intermediaries in one region.
Capacity execution and ramp risk
Medium300K sq ft of 50-acre greenfield to be operational Q2 end; full utilization expected in 18–24 months. If market demand slows or capacity overshoots demand, ROI at risk.
Reynolds integration and profitability
MediumReynolds brand & assets acquisition integration is underway. FY27 contribution minimal; full potential unlock tied to 50-acre plant capacity commissioning Q2 end. If brand fails to gain traction or production costs exceed plan, value dilution risk.
Competitive pricing and market share defense
LowCompany chose 4–5% price hikes vs 20% RM inflation to defend market share against unorganized competitors. Strategy logic sound but creates margin trough lasting FY27–FY28.
Management
Score 7/10. Candid on margin pressures; transparent cost breakdowns (ESOP +0.2%, facility +0.4%, RM –400 bps). Detailed on strategy rationale. Limited hedging on RM outlook; deferred FY28 guidance appropriately. Hit FY27 revenue guidance (19.2%). Missed margin guidance (12.3% vs prior 16–17%). Capex on track (₹100 Cr invested Q1 of ₹250–275 Cr plan). Capacity expansion timeline credible.
1 · Q2 FY27
300K sq ft capacity operational; diaper seasonality ramp begins
2 · H2 FY27
New pencil, eraser, pen volumes ramp; export capacity utilization gains
3 · Q3–Q4 FY27
Reynolds manufacturing begins at 50-acre facility; capex peak
Long-term positioning solid, but FY27–28 profitability at risk.
Informational and educational content only. Not investment advice.